CompoAtlas

Jiawei Yinqiao Tablet

Jiawei Yinqiao Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL12055060T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
J.D. ACADEMY
Manufacturer
SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD.
Importer
J.D. ACADEMY
Registration period starting
2022-06-02
Published validity end
2027-06-02

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Mentha haplocalyxMentha haplocalyx[12.4mg;600mg]Not identified
SOJAE PRAEPARATUMSOJAE PRAEPARATUM[10.15mg;600mg]Not identified
Arctium lappaArctium lappa[30.2mg;600mg]Not identified
Lophatherum gracileLophatherum gracile[8.5mg;600mg]Not identified
Schizonepeta tenuifoliaSchizonepeta tenuifolia[8.5mg;600mg]Not identified
Platycodon grandiflorumPlatycodon grandiflorum[236mg;600mg]Not identified
Lonicera japonicaLonicera japonica[10.15mg;600mg]Not identified
Forsythia suspensaForsythia suspensa[19.30mg;600mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[10.15mg;600mg]Not identified
Rehmannia glutinosaRehmannia glutinosa[236mg;600mg]Not identified
Gardenia jasminoidesGardenia jasminoides[8.5mg;600mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Mentha haplocalyx[12.4mg;600mg],SOJAE PRAEPARATUM[10.15mg;600mg],Arctium lappa[30.2mg;600mg],Lophatherum gracile[8.5mg;600mg],Schizonepeta tenuifolia[8.5mg;600mg],Platycodon grandiflorum[236mg;600mg],Lonicera japonica[10.15mg;600mg],Forsythia suspensa[19.30mg;600mg],Lonicera japonica[10.15mg;600mg],Glycyrrhiza uralensis[10.15mg;600mg],Rehmannia glutinosa[236mg;600mg],Gardenia jasminoides[8.5mg;600mg]
Valid until
2027-06-02
Registration date
2022-06-02
Published description
NATURAL PRODUCT
Licence holder
J.D. ACADEMY
Importer
J.D. ACADEMY
Producer
SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD.
Published name
Jiawei Yinqiao Tablet
Published reference
201011120003T
Registration number
MAL12055060T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL12055060T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Arctium lappa
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line